N-Nitroso Eltrombopag Amino Impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

N-Nitroso Eltrombopag Amino Impurity

● Failure Report (NAP Test) Available

Catalogue No.:VE0024456
CAS No.:N/A
Mol. Formula:C13H10N2O4
Mol. Weight:258.23 g/mol

Additional information on N-Nitroso Eltrombopag Amino Impurity

Parent drug

Eltrombopag

IUPAC Name

2′-hydroxy-3′-(nitrosoamino)-[1, 1′-biphenyl]-3-carboxylic acid

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=C(O)C1=CC(C2=CC=CC(NN=O)=C2O)=CC=C1

InChI

InChI=1S/C13H10N2O4/c16-12-10(5-2-6-11(12)14-15-19)8-3-1-4-9(7-8)13(17)18/h1-7, 16H, (H, 14, 19)(H, 17, 18)

Description

N-Nitroso Eltrombopag Amino Impurity is an N-nitroso derivative of the secondary amine present in Eltrombopag, which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds including those set by USP, EMA, JP and BP. This nitroso standard is essential for a variety of applications such as analytical method development method validation (AMV) and Quality Control (QC) particularly in the context of Eltrombopag production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits quantify impurity levels and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

N-Nitroso-Eltrombopag Amino-Impurity: Synthesis Attempts and Failure Report (NAP Test)

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url